Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
Clinical trial NCT05678673 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05678673
- Sponsor
- Exelixis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2026-12-15
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.